Imaging Biometrics Ltd. (IQAIF) Research
IQ-AI Limited is dedicated to advancing healthcare by developing and commercializing cutting-edge medical software and associated services. In March 2018, the company expanded its portfolio by acquiring Imaging Biometrics, LLC (IB), a Wisconsin, USA-based firm specializing in medical imaging software. Imaging Biometrics not only offers regulatory consulting but also delivers a variety of medical technology solutions, boasting a robust suite of neuroimaging products. These sophisticated analytical tools empower clinicians, enabling them to diagnose and treat diseases with enhanced precision and confidence. Notably, the integration of IB marked IQ-AI's second strategic acquisition within the medical imaging domain, following its purchase of Stone Checker Software Ltd in 2017.
Market snapshot
- Symbol
- IQAIF
- Price
- $0.02
- Day change
- 0.00%
- Market cap
- $1.7M
- P/E ratio
- -4.66x
- 52-week range
- 0.017-0.02
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
Peer companies
Open Imaging Biometrics Ltd. (IQAIF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.